InvestorsHub Logo

Zadie420

12/22/23 1:52 PM

#658383 RE: Rh2022 #658381

Exactly. This is the key to the whole thing besides getting the regulatory approval. Otherwise, MMs are in charge of PPS. Nothing can stop them. On top of that you are trading on the most relaxed, unregulated market known as OTC. I am hoping LP have something in her sleeves.

DavidW2

12/22/23 2:21 PM

#658396 RE: Rh2022 #658381

Sounds good but this company never do this for it's shareholders.

skitahoe

12/22/23 2:49 PM

#658402 RE: Rh2022 #658381

What sort of partnership are you speaking of. At current prices I don't believe that LP would partner with anyone who was taking stock ownership as a part of the partnership. A partner might pay double, even triple the current stock price, but nowhere near the double digit prices she's suggested in the past that it would take.

Of course other partnerships are possible. NWBO could partner to run trials with other drugs, both companies could provide support for running the trials, but no equity would be involved. I still believe a partnership, or contract, may be forthcoming with CRL for commercial manufacturing of DCVax-L, again the terms wouldn't have to involve stock in either company.

I believe most people are talking about a BP buying into NWBO, that certainly could happen in the future, but if LP sticks to her guns, it won't happen before the stock is at a price that the double digit price she'd want for NWBO stock in the partnership is within striking distance. Personally I believe double the current price is very achievable, perhaps even triple the current price is possible, but 10, 20, or 30 times the current stock price is not something any company will do, and that's what would be needed at current stock prices to meet LP's demand. I wouldn't want to see such a partnership at less than she's demanding.

Gary